Market Outlook

By 2035, the U.S. Outpatient Diagnostic Imaging Devices Market is expected to reach approximately USD 17.28 billion, expanding at a CAGR of 7.18% during the forecast period 2026–2035. The market was valued at approximately USD 8.64 billion in 2025, with historical analysis covering 2021 to 2024. Values in this report are expressed in USD billions.

For the purpose of this report, the market includes diagnostic imaging equipment, embedded device software, modality-specific accessories, system upgrades, detectors, transducers, coils, workstations, and equipment service revenue attributable to outpatient care settings. It covers independent diagnostic imaging centers, hospital outpatient departments, physician-owned imaging practices, specialty clinics, ambulatory surgery centers, urgent care facilities, mobile imaging providers, and emerging retail diagnostic locations. Imaging procedure revenue, contrast media, radiopharmaceuticals, radiation therapy systems, and inpatient-only equipment utilization are excluded.

The U.S. outpatient diagnostic imaging ecosystem has become a strategically important component of the national healthcare delivery system. Diagnostic imaging is increasingly performed outside the traditional inpatient environment as payers, health systems, physicians, and patients seek lower-cost access, faster scheduling, shorter waiting times, and more convenient care. Hospitals are expanding freestanding imaging facilities, radiology groups are consolidating independent centers, orthopedic and cardiology practices are installing dedicated systems, and mobile imaging providers are extending access into rural and underserved communities.

Demand is supported by the country’s aging population, cancer burden, musculoskeletal disease, cardiovascular conditions, neurological disorders, diabetes-related complications, preventive screening requirements, and continued growth in ambulatory medical encounters. More than 61 million U.S. residents were aged 65 or older by 2024, while approximately 2.1 million new cancer cases are expected to be diagnosed in 2026. These demographic and clinical realities create recurring demand for magnetic resonance imaging, computed tomography, ultrasound, digital radiography, mammography, positron emission tomography, and single-photon emission computed tomography.

The outpatient imaging market is also moving beyond conventional equipment replacement toward a more connected operating model. Purchasing decisions now consider examination throughput, scanner uptime, energy consumption, helium dependency, room preparation requirements, remote serviceability, technologist productivity, artificial intelligence integration, radiation-dose management, and interoperability with enterprise imaging systems. Outpatient operators frequently manage tighter margins than tertiary hospitals, making total cost of ownership and revenue per scanning hour central to capital decisions.

Historically, the market expanded from approximately USD 6.72 billion in 2021 to USD 8.11 billion in 2024. The recovery of elective imaging volumes, delayed equipment replacements, breast screening normalization, orthopedic procedure growth, outpatient oncology expansion, and greater adoption of portable ultrasound supported this increase. The market reached approximately USD 8.64 billion in 2025, reflecting stronger demand for high-throughput CT, wide-bore MRI, digital breast tomosynthesis, AI-enabled ultrasound, cloud-connected imaging workstations, and equipment modernization across independent and health-system-affiliated imaging networks.

Introduction

According to the U.S. Outpatient Diagnostic Imaging Devices Market Report, the market is being shaped by a structural redistribution of diagnostic activity across the healthcare system. Imaging remains essential to diagnosis, treatment planning, screening, procedural guidance, therapy monitoring, and post-treatment surveillance, but an increasing proportion of appropriate examinations can be performed in ambulatory locations rather than high-cost inpatient facilities.

Outpatient imaging is not a uniform business category. It includes large multisite radiology networks operating multiple CT, MRI, mammography, ultrasound, and nuclear imaging systems; hospital-owned freestanding centers connected to enterprise imaging infrastructure; orthopedic and sports medicine practices operating extremity MRI or cone-beam CT; cardiology clinics using echocardiography and vascular ultrasound; women’s health facilities focused on mammography and breast ultrasound; and mobile providers serving nursing facilities, rural communities, and home-based patients.

Independent diagnostic imaging centers represent an especially important demand base. More than 5,000 diagnostic imaging center businesses operate in the United States, generating procedure-related industry revenue substantially larger than the equipment market measured in this report. Their capital strategies are highly sensitive to reimbursement, referral density, payer contracts, scanner utilization, staffing availability, and debt-financing costs. Unlike academic hospitals, independent centers must frequently justify equipment investments against examination-level contribution margins and realistic daily scheduling capacity.

Hospital outpatient departments remain equally important because many integrated delivery networks are shifting suitable imaging volume into suburban and community locations. Outpatient services represented approximately 57% of hospital revenue by 2024, compared with 52% in 2020. Diagnostic imaging supports these ambulatory strategies by attracting referrals, feeding oncology and surgical service lines, reducing congestion at main campuses, and improving access in expanding population centers.

Market sizing was developed through a bottom-up and top-down triangulation process. The model considers the installed base of outpatient systems, estimated annual equipment replacement rates, new facility openings, modality-specific average selling prices, refurbished-equipment penetration, software and upgrade attachment rates, service-contract revenue, outpatient share of system utilization, and capital spending patterns across different provider types. This methodology separates device-market value from imaging-provider revenue and avoids treating reimbursement receipts as equipment sales.

From 2026 to 2035, the market will increasingly favor systems that permit outpatient operators to complete more examinations with fewer manual steps. Automated positioning, faster reconstruction, protocol standardization, remote scanning support, AI-assisted acquisition, predictive maintenance, simplified siting, and automated quality control will carry greater economic value than marginal improvements in image quality alone. The winning platforms will combine clinical performance with measurable gains in patient throughput and workforce efficiency.

Key Market Drivers: What’s Fueling the U.S. Outpatient Diagnostic Imaging Devices Market Boom?

The first major driver is the sustained migration of diagnostic care toward outpatient settings. Health systems are attempting to deliver appropriate services in lower-cost environments, commercial insurers frequently direct members toward independent imaging centers, and patients increasingly expect appointments outside congested hospital campuses. Medicare fee-for-service beneficiaries averaged approximately three hospital outpatient encounters per beneficiary in 2024, representing a 4% increase from 2023. Imaging is embedded across many of these encounters and remains one of the most important diagnostic capabilities supporting ambulatory care.

A second driver is the growing burden of cancer and the expansion of longitudinal oncology imaging. Approximately 2.1 million new cancer cases are expected to be diagnosed in the United States in 2026. Cancer care generates repeated imaging requirements across screening, staging, treatment selection, radiation planning, response assessment, recurrence surveillance, and survivorship. Outpatient PET/CT, CT, MRI, ultrasound, mammography, and image-guided biopsy capacity is therefore becoming essential to community oncology networks and hospital-affiliated cancer programs.

Breast imaging provides one of the clearest examples of recurring outpatient demand. By July 2026, U.S. mammography facilities were reporting nearly 44.8 million annual procedures. More than 9,100 certified facilities operated over 27,600 accredited mammography units, including approximately 13,500 digital breast tomosynthesis units. The continuing transition toward tomosynthesis, contrast-enhanced mammography, AI-assisted detection, density assessment, and coordinated breast ultrasound is supporting replacement and upgrade demand across dedicated women’s imaging centers.

A third driver is population aging. The U.S. population aged 65 and older reached approximately 61.2 million in 2024 and continues to grow faster than the overall population. Older adults use imaging more frequently because of higher rates of cancer, osteoarthritis, fractures, cardiovascular disease, stroke, neurodegenerative conditions, chronic kidney disease, and complex multimorbidity. Outpatient imaging centers are responding with wide-bore MRI, faster CT protocols, accessible examination tables, lower-dose systems, shortened scanning sequences, and designs that accommodate patients with mobility limitations.

A fourth driver is the scale of chronic disease. More than 40 million Americans have diabetes, and an estimated 37 million adults have chronic kidney disease. Diabetes and kidney disease increase demand for vascular ultrasound, cardiac imaging, abdominal imaging, musculoskeletal assessment, renal imaging, and evaluation of related complications. Approximately 129 million Americans are estimated to live with at least one major chronic disease, creating a durable base of repeat diagnostic utilization rather than one-time episodic demand.

A fifth driver is growing musculoskeletal imaging volume. Orthopedic practices, sports medicine clinics, pain-management centers, and ambulatory surgery networks rely heavily on MRI, ultrasound, digital radiography, and extremity imaging. Outpatient operators are investing in dedicated systems that can support high patient turnover without the infrastructure requirements of large hospital scanners. Compact MRI, standing CT, weight-bearing cone-beam CT, digital X-ray rooms, and point-of-care ultrasound are increasingly aligned with the economics of orthopedic care.

A sixth driver is the expansion of value-oriented capital procurement. Outpatient providers rarely evaluate equipment solely on technical specifications. Capital committees analyze scanner utilization, reimbursement per examination, service coverage, expected downtime, room modifications, power and cooling requirements, technologist training, consumable use, and resale value. Vendors that can reduce installation complexity or extend the productive life of an existing scanner may have an advantage over companies offering technically superior but operationally expensive systems.

A seventh driver is the shortage of radiologists and imaging technologists. Imaging demand has expanded faster than specialist capacity in several markets. The number of radiology-only practices declined by nearly one-third between 2014 and 2023, while average practice size increased from approximately 45 to 89 physicians. These changes indicate ongoing consolidation and the need for centralized reading, workflow automation, remote operations, standardized protocols, and AI-based prioritization across distributed outpatient networks.

An eighth driver is the growth of consumer-oriented access. Patients are increasingly comparing scheduling availability, insurance cost, location, examination duration, parking access, and reporting speed. This is encouraging providers to build suburban imaging centers, extend evening and weekend hours, introduce online scheduling, and offer transparent self-pay pricing. Equipment that supports rapid examination turnover, simplified workflow, and consistent quality across multiple sites is particularly valuable in this operating environment.

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in the U.S. outpatient diagnostic imaging devices market is increasingly centered on operating economics. Outpatient facilities need technology that can produce clinically reliable examinations while minimizing installation cost, staffing burden, retakes, downtime, and examination duration. Manufacturers are therefore redesigning imaging platforms around productivity, automation, modularity, remote support, and lifecycle flexibility.

Photon-counting CT is emerging as an important next-generation development. The technology directly counts individual X-ray photons and can provide higher spatial resolution, improved spectral information, and better tissue characterization than conventional detector architectures. Although early adoption is concentrated in premium institutions, the arrival of additional cleared platforms is expanding competition. Over time, simplified configurations and broader clinical evidence could make photon-counting systems relevant to high-volume outpatient oncology, cardiovascular, neurological, and musculoskeletal imaging.

Conventional CT systems are also improving through deep-learning reconstruction, automated positioning, faster workflow, and lower-dose acquisition. These capabilities are particularly relevant to outpatient centers, where a few minutes saved per examination can increase daily capacity. Automated protocol selection and image reconstruction can also reduce variability between technologists and facilities, helping multisite operators maintain consistent examination quality.

MRI innovation is focused on shorter scanning times, wider bores, simplified installation, reduced helium dependency, and AI-assisted reconstruction. Helium-light and closed-helium designs can lower infrastructure complexity and reduce exposure to helium supply volatility. Software-based reconstruction improvements allow providers to obtain higher-quality images from shorter acquisitions or upgrade the performance of an existing installed system without replacing the entire scanner.

Compact and lower-field MRI systems are opening additional outpatient opportunities. These systems can require less shielding, power, cooling, and construction than conventional high-field scanners. While they are not replacements for every advanced MRI application, they can support neurological, musculoskeletal, orthopedic, and targeted diagnostic workflows in locations where a traditional MRI installation would be financially or structurally difficult.

Ultrasound is becoming more automated and distributed. AI-enabled measurements, automated cardiac quantification, lesion characterization, image optimization, and guided acquisition are reducing operator dependency. Portable and handheld devices are expanding ultrasound use in cardiology practices, vascular clinics, women’s health centers, urgent care facilities, and mobile imaging services. The segment is moving from standalone hardware sales toward recurring software, cloud connectivity, and application-specific subscriptions.

Women’s imaging is advancing through digital breast tomosynthesis, contrast-enhanced mammography, AI-based lesion detection, automated density reporting, abbreviated breast MRI, and more integrated biopsy workflows. Because breast screening is largely outpatient and produces recurring annual or biennial utilization, women’s imaging remains one of the most strategically attractive modality categories for manufacturers.

Nuclear imaging innovation is focused on digital detectors, improved time-of-flight performance, higher sensitivity, faster scans, lower administered dose, and expanded theranostic workflows. Community oncology programs and outpatient molecular imaging centers are investing selectively in PET/CT and SPECT/CT as oncology and neurological applications expand. The availability of radiopharmaceuticals and local reimbursement remains a critical determinant of system utilization.

Imaging informatics is becoming a central competitive layer. Cloud-based picture archiving and communication systems, vendor-neutral archives, enterprise worklists, AI orchestration, automated prior-study retrieval, structured reporting, and image exchange can connect distributed outpatient sites to centralized radiologists. For multisite operators, the strategic value of a scanner increasingly depends on how effectively it participates in this broader digital workflow.

Remote scanning and command-center models are also gaining relevance. Experienced technologists can supervise protocols or support examinations across multiple sites, helping providers cover staffing gaps and standardize operations. This model is particularly attractive for imaging chains that operate a large number of geographically dispersed centers with variable local workforce availability.

Predictive maintenance is another important innovation area. Scanner downtime can directly eliminate revenue for an outpatient center because patients may have to be rescheduled or referred to a competitor. Connected service platforms use system-performance data to identify component degradation, schedule maintenance, and support remote troubleshooting. Vendors that provide strong uptime guarantees and responsive service coverage can influence purchasing decisions even when equipment specifications are similar.

Segmentation Insights

The U.S. Outpatient Diagnostic Imaging Devices Market is segmented on the basis of modality, application, end user, technology configuration, and region.

By Modality

Computed Tomography Systems

Computed tomography represented the largest modality segment in 2025, generating an estimated USD 2.08 billion in outpatient-attributable equipment, software, upgrade, and service revenue. CT is central to oncology, pulmonary imaging, cardiovascular assessment, emergency diagnostics, trauma follow-up, abdominal imaging, and image-guided procedures. High-volume outpatient centers favor scanners that combine fast acquisition, automated patient positioning, low-dose protocols, and rapid reconstruction.

Replacement demand is shifting from basic slice-count comparisons toward spectral capabilities, cardiac imaging performance, examination automation, and advanced reconstruction. Premium photon-counting systems will initially remain concentrated in large networks and academic-affiliated outpatient campuses, while mainstream centers are likely to invest in high-throughput conventional CT platforms with upgradeable software architectures.

Magnetic Resonance Imaging Systems

MRI accounted for approximately USD 1.79 billion in 2025 and is expected to be one of the fastest-growing high-value modality categories. Demand is strongest in musculoskeletal, neurological, spine, oncology, prostate, breast, and cardiovascular imaging. MRI is especially important to independent centers because it supports strong referral relationships with orthopedic surgeons, neurologists, oncologists, pain specialists, and sports medicine practices.

Wide-bore 1.5T systems remain the commercial center of the outpatient market because they balance image quality, patient acceptance, clinical versatility, and acquisition cost. Premium 3T systems are increasingly used by advanced orthopedic, neurological, and oncology centers. Compact and lower-field platforms can expand access in smaller facilities, physician offices, and markets where construction requirements would otherwise limit adoption.

Ultrasound Imaging Systems

Ultrasound generated an estimated USD 1.47 billion in 2025. The segment includes cart-based systems, compact platforms, handheld devices, transducers, software applications, and related service revenue. Outpatient demand spans cardiology, vascular medicine, obstetrics, gynecology, breast imaging, abdominal imaging, urology, musculoskeletal assessment, and procedural guidance.

Ultrasound benefits from the absence of ionizing radiation, relatively low capital cost, and flexibility across care settings. AI-enabled measurements and guided acquisition are expanding the addressable user base. Handheld systems are expected to grow rapidly, although premium cart-based platforms will remain essential for echocardiography, vascular studies, breast imaging, and complex women’s health examinations.

Digital X-Ray and Fluoroscopy Systems

Digital radiography and outpatient fluoroscopy represented approximately USD 1.31 billion in 2025. The segment includes fixed digital X-ray rooms, mobile radiography, digital detectors, radiography-fluoroscopy systems, and specialty configurations. Orthopedic practices, urgent care centers, occupational health clinics, ambulatory surgery centers, and imaging centers generate substantial recurring demand.

The market is being driven by detector upgrades, wireless workflow, automated positioning, dose optimization, and integration with cloud-based image management. Although digital X-ray is more mature than CT or MRI, its high examination volume and large installed base create recurring replacement and upgrade opportunities.

Mammography and Breast Imaging Systems

Mammography and breast imaging accounted for approximately USD 1.20 billion in 2025. The segment includes full-field digital mammography, digital breast tomosynthesis, breast ultrasound, contrast-enhanced mammography capabilities, stereotactic biopsy systems, and associated AI applications.

More than 90% of certified U.S. mammography facilities have adopted digital breast tomosynthesis capability or operate within a facility offering it. Future growth will come from replacement of first-generation tomosynthesis platforms, AI-supported detection, automated density assessment, contrast-enhanced mammography, integrated biopsy workflow, and coordinated imaging pathways for women with dense breasts or elevated cancer risk.

Nuclear Imaging and Molecular Imaging Systems

PET, PET/CT, SPECT, and SPECT/CT generated an estimated USD 0.79 billion in 2025. Outpatient molecular imaging demand is primarily linked to oncology, cardiology, neurology, and emerging theranostic care pathways. The segment is smaller by installed unit count but carries high equipment values and complex service requirements.

Growth will depend on radiopharmaceutical availability, oncology referral networks, reimbursement, examination throughput, and adoption of digital detector technology. Outpatient oncology centers with sufficient patient density are likely to invest in faster systems that reduce scan time and improve scheduling economics.

 

By Application

Oncology Imaging

Oncology represents the largest application segment. CT, MRI, PET/CT, ultrasound, mammography, and image-guided biopsy are used across the full cancer-care pathway. The increasing number of cancer survivors also creates long-term surveillance demand extending years beyond initial treatment.

Outpatient oncology networks require equipment capable of supporting consistent quantitative assessment, comparison with prior studies, structured reporting, and integration with radiation oncology and treatment-planning systems. Manufacturers that can connect diagnostic imaging to longitudinal oncology workflows are positioned to capture a larger share of capital spending.

Musculoskeletal and Orthopedic Imaging

Musculoskeletal imaging is a major source of outpatient MRI, X-ray, ultrasound, and cone-beam CT demand. Orthopedic practices increasingly seek control over scheduling and diagnostic turnaround, encouraging investment in in-office or affiliated imaging capacity.

Equipment selection is influenced by the clinical mix of spine, joint, sports injury, extremity, and postoperative cases. Dedicated extremity systems, weight-bearing imaging, faster musculoskeletal MRI protocols, and automated measurements are likely to gain adoption in high-volume specialty networks.

Cardiovascular and Vascular Imaging

Cardiovascular and vascular applications include echocardiography, vascular ultrasound, coronary CT angiography, cardiac MRI, nuclear cardiology, and peripheral vascular assessment. Growth is being supported by aging, diabetes, obesity, hypertension, structural heart follow-up, and demand for noninvasive assessment before more expensive procedures.

Outpatient cardiology groups prioritize examination efficiency, automated quantification, reproducibility, and integration with clinical information systems. Ultrasound remains the largest equipment category within this application, while cardiac CT and MRI represent premium growth opportunities.

Women’s Health Imaging

Women’s health imaging includes mammography, breast ultrasound, breast MRI, obstetric ultrasound, gynecological ultrasound, bone-density assessment, and related biopsy procedures. Screening recommendations and state-level breast-density notification requirements create repeat diagnostic demand.

The segment is increasingly organized around integrated breast centers capable of screening, diagnostic workup, ultrasound, biopsy, and risk-based supplemental imaging. Providers that reduce the interval between an abnormal screening result and definitive diagnosis can improve both patient experience and clinical outcomes.

Neurological Imaging

Neurological applications include brain and spine MRI, head CT, PET imaging, seizure assessment, multiple sclerosis monitoring, dementia evaluation, and imaging of cerebrovascular disease. An aging population and increased attention to early neurological diagnosis are expanding outpatient demand.

Dedicated neurological MRI, accelerated sequences, AI-supported lesion analysis, volumetric assessment, and compact scanners are important areas of development. Neurology practices and specialized brain-health centers may become more direct purchasers as systems become easier to site and operate.

General, Abdominal, Pulmonary and Other Imaging

This segment includes abdominal, renal, gastrointestinal, pulmonary, endocrine, urological, and general diagnostic imaging. Lung cancer screening, renal disease, liver disease, abdominal pain, and postoperative follow-up contribute substantial CT and ultrasound volume.

Outpatient facilities serving primary care and multispecialty referral networks require broad clinical flexibility rather than highly specialized equipment. Reliability, protocol breadth, reimbursement compatibility, and rapid reporting are therefore central purchasing criteria.

 

By End User

Independent Diagnostic Imaging Centers

Independent diagnostic imaging centers represent the largest end-user segment. Their purchasing behavior is driven by local referral density, payer contracts, expected daily volume, reimbursement per examination, and the competitive supply of nearby imaging capacity. These centers frequently operate extended hours and rely on high scanner utilization to generate attractive returns.

Large imaging chains can negotiate enterprise contracts, standardize systems, centralize reading, and spread service costs across multiple facilities. Smaller operators may favor refurbished equipment, flexible financing, managed services, or vendor-neutral software that avoids dependence on a single manufacturer.

Hospital Outpatient Departments and Freestanding Health-System Centers

Hospital outpatient departments and health-system-owned freestanding facilities account for a substantial share of premium equipment demand. These providers often require compatibility with enterprise imaging, electronic health records, cybersecurity standards, and hospital-wide quality protocols.

Health systems use outpatient imaging sites to extend geographic reach, capture referrals, decompress main campuses, and create downstream demand for oncology, surgery, cardiology, and specialty care. Their capital decisions increasingly evaluate network-wide capacity rather than the requirements of one facility.

Physician Offices and Specialty Clinics

Orthopedic, cardiology, obstetric, gynecology, urology, neurology, and sports medicine practices are important purchasers of ultrasound, digital X-ray, compact MRI, cone-beam CT, and specialty imaging systems. Ownership can improve scheduling control, shorten diagnostic pathways, and retain revenue within the practice.

Regulatory requirements, self-referral rules, accreditation, supervision standards, and payer credentialing influence adoption. Systems designed for simplified operation and lower infrastructure requirements are best positioned in this segment.

Ambulatory Surgery Centers and Urgent Care Facilities

Ambulatory surgery centers use mobile C-arms, ultrasound, digital radiography, and selected advanced imaging technologies for procedural guidance and perioperative assessment. Urgent care centers are significant users of digital X-ray and are beginning to adopt compact ultrasound for selected applications.

Demand is linked to the continuing shift of appropriate procedures away from hospitals. Equipment must fit smaller rooms, support rapid turnover, and require limited specialized staffing. Service responsiveness is particularly important because many facilities do not have redundant imaging capacity.

Mobile, Rural, Retail and Community Imaging Providers

Mobile imaging providers serve skilled nursing facilities, rural communities, physician practices, employers, and home-based patients. Their equipment needs include portable X-ray, handheld ultrasound, mobile mammography, and transportable scanning systems.

Rural markets face lower patient density and longer travel distances, making conventional fixed-site investment difficult. Mobile technology, tele-radiology, cloud image transfer, and remote quality assurance can improve access while creating new equipment demand. Retail and preventive imaging models remain emerging but could become commercially relevant if they demonstrate clinical value and secure reimbursement.

 

By Technology Configuration

Fixed High-Capacity Imaging Systems

Fixed systems dominate market value and include conventional MRI, CT, PET/CT, SPECT/CT, mammography, radiography, and high-end ultrasound platforms. These systems provide the broadest clinical capability and support the highest examination volumes.

Outpatient purchasers increasingly favor modular platforms that can receive future detector, software, reconstruction, and clinical application upgrades. Upgradability helps protect capital investment and can postpone full scanner replacement.

Compact and Space-Efficient Systems

Compact systems address providers with limited room, electrical capacity, structural support, or construction budgets. Compact CT, extremity MRI, lower-field MRI, cone-beam CT, and simplified digital X-ray configurations can expand imaging into specialty practices and community settings.

The economic value of these systems lies in their ability to create diagnostic capacity where a conventional installation would not be viable. Manufacturers must nevertheless demonstrate that reduced footprint does not create unacceptable clinical limitations.

Mobile and Portable Imaging Devices

Mobile and portable systems include handheld ultrasound, portable X-ray, mobile C-arms, transportable CT, mobile mammography, and selected compact MRI devices. This category is expected to grow above the market average through 2035.

Adoption is being supported by decentralization, home-based care, rural access programs, nursing-facility imaging, emergency preparedness, and demand for point-of-care diagnosis. Connectivity, battery life, infection control, ruggedness, and cloud-based image transfer are key differentiators.

AI-Enabled and Software-Defined Imaging Platforms

AI-enabled platforms use software to improve acquisition, reconstruction, protocol selection, image quality, lesion detection, measurements, worklist prioritization, and reporting. Radiology accounts for the majority of FDA-authorized AI-enabled medical devices, reflecting the suitability of imaging data for algorithmic analysis.

The commercial model is moving toward annual subscriptions, enterprise licenses, usage-based fees, and software upgrades. Outpatient providers will favor applications that demonstrate measurable reductions in scan time, retakes, reporting delay, or staffing burden rather than algorithms offering limited workflow benefit.

Refurbished, Upgraded and Managed-Equipment Solutions

Refurbished systems remain important for smaller imaging centers, rural facilities, physician practices, and operators entering new markets. Professionally refurbished MRI, CT, ultrasound, and radiography systems can provide clinically adequate performance at substantially lower acquisition cost.

Managed-equipment services, operating leases, and pay-per-use arrangements can reduce upfront capital requirements. Demand for upgrades is also increasing as providers seek to add AI reconstruction, new coils, digital detectors, or advanced clinical applications to existing equipment.

 

Regional Insights: Where the Market is Growing Fastest

The U.S. Outpatient Diagnostic Imaging Devices Market is geographically segmented into the South, West, Northeast, and Midwest. Regional performance differs according to population growth, age distribution, chronic disease prevalence, outpatient facility density, hospital consolidation, payer mix, specialist availability, rural access, capital availability, and adoption of advanced imaging technology.

The South represented the largest regional market in 2025, while the West is expected to grow at the fastest rate through 2035. The Northeast remains a high-value market characterized by dense specialist networks and premium technology adoption. The Midwest provides a stable installed base and significant demand for replacement equipment, rural access technologies, and cost-efficient imaging platforms.

South

The South accounted for an estimated USD 3.05 billion in 2025 and is projected to reach approximately USD 5.98 billion by 2035. The region includes Texas, Florida, Georgia, North Carolina, Virginia, Tennessee, South Carolina, Maryland, Delaware, West Virginia, Kentucky, Alabama, Mississippi, Louisiana, Arkansas, Oklahoma, and the District of Columbia.

Regional leadership is supported by population growth, large metropolitan healthcare markets, high chronic disease prevalence, expanding Medicare enrollment, new ambulatory facilities, and significant migration into suburban communities. The South also contains many rural and medically underserved areas, creating simultaneous demand for premium metropolitan imaging centers and portable community-access technologies.

Texas is the largest state market in the region. Houston, Dallas–Fort Worth, Austin, and San Antonio support extensive health systems, oncology networks, orthopedic practices, cardiology groups, and independent imaging operators. Rapid suburban expansion is encouraging construction of freestanding centers equipped with CT, MRI, mammography, ultrasound, and digital radiography. The state is also an important market for mobile services covering rural counties and long-distance referral areas.

Florida is one of the most strategically attractive outpatient imaging markets because of its large older-adult population. Demand is particularly strong for oncology imaging, breast imaging, cardiovascular ultrasound, neurological MRI, PET/CT, musculoskeletal imaging, and monitoring of chronic disease. Miami, Tampa, Orlando, Jacksonville, and Southwest Florida contain dense networks of outpatient providers and physician-owned practices.

North Carolina and Georgia are fast-growing markets supported by migration, healthcare investment, and expanding metropolitan areas. Charlotte, Raleigh–Durham, Atlanta, Savannah, and other urban centers are attracting new outpatient facilities. North Carolina also benefits from major academic medical systems and research institutions that influence adoption of advanced imaging and AI-enabled workflow.

Virginia and Maryland combine affluent suburban populations, large health systems, federal healthcare activity, and substantial specialist density. Northern Virginia, Richmond, Hampton Roads, Baltimore, and the Washington metropolitan area support premium MRI, CT, breast imaging, and cardiovascular diagnostic demand. The District of Columbia is smaller by equipment volume but has high-value academic and specialty facilities.

Tennessee and South Carolina are growing through health-system expansion and population movement into Nashville, Knoxville, Chattanooga, Memphis, Charleston, Columbia, and Greenville. Orthopedic, oncology, and cardiovascular imaging demand is particularly important. South Carolina is also one of the states with direct mammography-certification responsibilities, reinforcing the regulatory importance of breast-imaging quality infrastructure.

Alabama, Mississippi, Louisiana, Arkansas, Kentucky, and West Virginia have high burdens of diabetes, obesity, cardiovascular disease, kidney disease, and cancer. These states generate strong clinical need but face uneven access, rural hospital pressure, and imaging-workforce shortages. Capital opportunities are concentrated in regional referral centers, while portable ultrasound, mobile X-ray, mobile mammography, refurbished systems, and tele-radiology-enabled facilities can improve coverage outside metropolitan areas.

Oklahoma combines growing urban demand in Oklahoma City and Tulsa with large rural service areas. Delaware has a smaller population but benefits from access to the Philadelphia, Baltimore, and Washington healthcare corridors. Across the South, vendors that provide flexible financing, strong service networks, remote support, and equipment suitable for both high-volume and access-limited settings will be positioned favorably.

West

The West accounted for an estimated USD 2.11 billion in 2025 and is projected to reach approximately USD 4.59 billion by 2035, representing the fastest regional growth. The region includes California, Washington, Arizona, Colorado, Oregon, Nevada, Utah, New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii.

Growth is being driven by technology adoption, population movement, outpatient health-system expansion, digital-health integration, and demand for imaging capacity in both dense urban markets and geographically isolated communities. The West is particularly receptive to AI-enabled workflow, cloud-native imaging, portable devices, remote operations, and consumer-oriented screening models.

California is the largest state market in the West and one of the largest in the country. Los Angeles, San Diego, San Francisco, Sacramento, Orange County, and the Inland Empire support extensive health systems, imaging chains, oncology centers, orthopedic groups, and technology-oriented provider networks. California is an early-adoption market for advanced MRI, spectral and photon-counting CT, AI-enabled mammography, digital PET, enterprise imaging, and remote workflow tools.

Arizona and Nevada are high-growth markets because of population expansion, retirement migration, and rising healthcare construction. Phoenix, Tucson, Las Vegas, and Reno are adding outpatient capacity for musculoskeletal, cardiovascular, neurological, and oncology imaging. Wide-bore MRI and high-throughput CT are particularly relevant because of older and increasingly complex patient populations.

Washington and Oregon have sophisticated integrated delivery networks and strong adoption of digital healthcare infrastructure. Seattle, Spokane, Portland, and surrounding suburban markets support advanced imaging and centralized radiology models. Providers in these states often prioritize sustainability, energy use, remote service, enterprise interoperability, and equipment lifecycle management.

Colorado and Utah have growing populations, strong health systems, and expanding sports medicine and orthopedic markets. Denver, Colorado Springs, Salt Lake City, and rapidly developing suburban communities generate demand for MRI, digital radiography, ultrasound, and outpatient oncology imaging. Utah also benefits from a relatively young but fast-growing population, creating demand across women’s health and general diagnostic imaging.

New Mexico, Idaho, Montana, and Wyoming have lower population density and significant rural-access requirements. Albuquerque, Boise, and selected regional centers support fixed advanced imaging, while mobile systems and tele-radiology are important for remote communities. Providers must balance clinical breadth with realistic patient volumes, increasing the appeal of compact or refurbished equipment.

Alaska and Hawaii face unique logistics, service, and supply-chain challenges. Equipment installation, spare-parts availability, and engineer travel can materially affect lifecycle cost. Reliable remote diagnostics, extended service coverage, portable systems, and equipment capable of supporting broad applications are therefore strategically important.

The West’s growth will be supported by outpatient expansion, innovation adoption, and demand for decentralized diagnostics. Manufacturers that combine advanced technology with flexible siting and digital connectivity are likely to gain share.

Northeast

The Northeast represented approximately USD 1.85 billion in 2025 and is projected to reach around USD 3.63 billion by 2035. The region includes New York, Pennsylvania, New Jersey, Massachusetts, Connecticut, Rhode Island, New Hampshire, Maine, and Vermont.

The Northeast is a mature but high-value market. It has dense specialist networks, major academic medical centers, advanced cancer programs, strong commercial insurance coverage, and high utilization of sophisticated diagnostic services. Capital purchasing is rigorous and frequently requires detailed clinical evidence, cybersecurity review, interoperability testing, and health-economic justification.

New York is the largest state market in the region. New York City, Long Island, Westchester County, Buffalo, Rochester, Albany, and Syracuse support extensive outpatient imaging networks. High population density creates strong examination volumes, but operators face elevated real estate, construction, staffing, and regulatory costs. Compact equipment, high throughput, and reduced room requirements therefore carry substantial economic value.

Pennsylvania has large imaging markets in Philadelphia, Pittsburgh, Harrisburg, Allentown, and surrounding communities. The state combines major academic systems with community hospitals, orthopedic groups, and independent centers. Demand spans oncology, musculoskeletal, cardiovascular, women’s health, and general imaging.

New Jersey benefits from dense suburban populations and proximity to the New York and Philadelphia markets. It has a large base of physician practices, freestanding imaging centers, and health-system facilities. Competition is intense, making patient access, scheduling speed, equipment quality, and payer participation important commercial differentiators.

Massachusetts is influential because of its concentration of academic institutions, medical technology companies, research programs, and premium clinical services. Although the state’s population is smaller than New York or Pennsylvania, it is a significant early-adoption market for advanced MRI, AI-enabled workflow, digital PET, breast imaging, and cloud-based informatics.

Connecticut and Rhode Island support mature outpatient networks with relatively high insurance coverage and specialist density. New Hampshire, Maine, and Vermont have older populations and substantial rural or semi-rural service areas. These northern states require a combination of advanced systems in regional centers and distributed access through community hospitals, mobile providers, and tele-radiology.

Growth in the Northeast will be driven more by equipment replacement, software upgrades, center consolidation, and premium modality adoption than by rapid facility expansion. Vendors with strong service organizations, enterprise integration, and evidence-based value propositions will be best positioned.

Midwest

The Midwest accounted for approximately USD 1.63 billion in 2025 and is expected to reach approximately USD 3.08 billion by 2035. The region includes Illinois, Ohio, Michigan, Minnesota, Indiana, Wisconsin, Missouri, Iowa, Kansas, Nebraska, North Dakota, and South Dakota.

The Midwest has a large installed base of hospital-affiliated and independent imaging systems. Market growth is supported by replacement cycles, chronic disease burden, regional referral networks, orthopedic demand, oncology expansion, and the need to improve rural diagnostic access. Buyers often place a high value on equipment reliability, service responsiveness, financing flexibility, and standardized contracts.

Illinois is the largest state market in the region. Chicago and its suburbs support major academic hospitals, health systems, imaging networks, oncology centers, and physician practices. Downstate Illinois contains smaller cities and rural communities that require cost-efficient equipment and tele-radiology support.

Ohio has strong outpatient imaging demand across Cleveland, Columbus, Cincinnati, Dayton, and Toledo. Large health systems and specialty practices support MRI, CT, PET/CT, ultrasound, and women’s imaging investment. Michigan has similar demand across Detroit, Grand Rapids, Ann Arbor, and regional population centers, with particularly strong musculoskeletal, cardiovascular, and oncology imaging requirements.

Minnesota is strategically important because of its medical technology ecosystem and concentration of sophisticated provider organizations. The state is a strong market for enterprise imaging, advanced modality systems, workflow automation, and remote-care technology. Wisconsin and Indiana provide stable demand across Milwaukee, Madison, Indianapolis, Fort Wayne, and regional health systems.

Missouri, Iowa, and Kansas contain large regional referral networks and significant rural populations. St. Louis, Kansas City, Des Moines, and Wichita support advanced fixed-site imaging, while smaller communities require mobile services, refurbished equipment, and remote reading capacity.

Nebraska, North Dakota, and South Dakota are smaller equipment markets but important for rural-access solutions. Long travel distances and low patient density can make full-scale imaging centers difficult to support. Portable devices, regional hub-and-spoke networks, shared mobile systems, and connected imaging platforms are therefore particularly relevant.

The Midwest is expected to grow more steadily than the West or South, but its large replacement base and need for dependable service create durable opportunities. Manufacturers that offer practical productivity improvements rather than unnecessary technical complexity are likely to perform well.

 

Key Market Players

The U.S. Outpatient Diagnostic Imaging Devices Competitive Landscape is moderately consolidated in major capital-equipment categories. GE HealthCare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems, Fujifilm Healthcare, and Hologic hold strong positions across MRI, CT, ultrasound, radiography, mammography, molecular imaging, and imaging informatics.

Competition is increasingly based on platform breadth and lifecycle economics. Major manufacturers can bundle equipment, service, upgrades, financing, informatics, and AI applications across multiple facilities. This is attractive to large outpatient chains and integrated health systems seeking vendor standardization.

Specialized companies compete through compact systems, portable imaging, breast-specific technology, cloud-native software, cone-beam CT, low-field MRI, handheld ultrasound, and workflow applications. These companies can gain adoption when their products solve specific space, staffing, access, or specialty-care problems that broad-platform vendors do not address effectively.

Some of the key players in the U.S. Outpatient Diagnostic Imaging Devices industry are:

GE HealthCare
Siemens Healthineers
Philips Healthcare
Canon Medical Systems USA
FUJIFILM Healthcare Americas
Hologic
Carestream Health
Samsung Healthcare
United Imaging Healthcare America
Konica Minolta Healthcare Americas
Esaote North America
Agfa HealthCare
Shimadzu Medical Systems USA
Ziehm Imaging
Mindray North America
Butterfly Network
Hyperfine
CurveBeam AI
Delphinus Medical Technologies
Planmed USA
NeuroLogica
Sectra
Intelerad
Nano-X Imaging
Clarius Mobile Health

GE HealthCare maintains a broad U.S. installed base and competes across CT, MRI, ultrasound, nuclear imaging, radiography, AI reconstruction, and enterprise workflow. Siemens Healthineers has a strong position in premium CT, MRI, molecular imaging, mammography, and imaging services. Philips is differentiated by MRI workflow, ultrasound, image-guided systems, informatics, and software upgrades that can improve existing installed systems.

Canon Medical competes through CT, MRI, ultrasound, and X-ray platforms, while Fujifilm combines imaging equipment with enterprise informatics and endoscopy-related capabilities. Hologic is especially influential in women’s health and mammography. United Imaging is expanding competition through premium imaging platforms and aggressive value positioning.

Butterfly Network, Clarius, and Mindray support the expansion of portable and handheld ultrasound. Hyperfine is developing portable MRI use cases. CurveBeam AI is focused on weight-bearing and orthopedic cone-beam CT. Delphinus and Planmed address specialized breast and compact imaging applications. Sectra, Intelerad, Agfa HealthCare, and other informatics providers influence purchasing by connecting equipment across distributed outpatient networks.

Market share through 2035 will be determined by total cost of ownership, scanner uptime, service coverage, financing, clinical application depth, AI integration, cybersecurity, interoperability, upgradeability, and evidence that a system can improve examinations completed per operating hour.

 

Recent Developments

Recent developments in the U.S. Outpatient Diagnostic Imaging Devices Market demonstrate a shift toward advanced detector technology, software-defined performance, lower infrastructure requirements, and more automated workflow.

Photon-counting CT competition accelerated during 2025 and 2026. Siemens Healthineers received U.S. clearance for an expanded Naeotom Alpha product class in 2025, including dual-source and single-source configurations. GE HealthCare received FDA clearance for its Photonova Spectra system in March 2026. The entry of multiple platforms is expected to increase clinical evidence generation and gradually broaden access beyond flagship academic institutions.

MRI development has focused on installation efficiency and helium reduction. Siemens Healthineers received clearance for Magnetom Flow.Ace in 2025 and a 70-centimeter-bore Magnetom Flow platform in 2026, both designed around closed-helium technology. These developments are relevant to outpatient centers because they can reduce quench-pipe requirements, simplify siting, and lower exposure to helium-related operating risk.

Software upgrades are becoming a larger source of market value. Philips received FDA clearance in 2025 for SmartSpeed Precise, extending dual-AI reconstruction capability across its 1.5T and 3T MRI portfolio. Installed-base software strategies allow outpatient operators to improve image quality or scanning speed without undertaking immediate full-system replacement.

CT reconstruction also advanced in 2026, with GE HealthCare receiving clearance for True Definition DL. Deep-learning reconstruction technologies can improve spatial resolution and suppress artifacts, supporting faster or lower-dose imaging workflows. These capabilities are commercially valuable to outpatient centers seeking to increase capacity without adding another scanner.

Women’s imaging continued to evolve through contrast-enhanced mammography, biopsy integration, AI-supported detection, and tomosynthesis upgrades. In June 2026, new contrast-enhanced mammography and biopsy capabilities were cleared for the Siemens Mammomat B.brilliant platform. The U.S. mammography installed base also continued to expand, with approximately 13,500 accredited digital breast tomosynthesis units reported by July 2026.

The FDA-authorized AI-enabled medical device landscape expanded rapidly, with radiology accounting for the largest clinical category. Imaging companies are increasingly embedding AI into acquisition, reconstruction, triage, measurement, lesion detection, and workflow orchestration rather than selling it only as a separate application.

Industry consolidation is also shaping outpatient purchasing. Independent radiology practices are becoming larger, hospital systems are standardizing technology across ambulatory networks, and major imaging operators are negotiating enterprise-level equipment and service contracts. As purchasing becomes more centralized, suppliers will require national service capabilities, predictable implementation, and scalable software architectures.

 

Conclusion

The U.S. Outpatient Diagnostic Imaging Devices Market Size & Share is positioned to expand from approximately USD 8.64 billion in 2025 to USD 17.28 billion by 2035, registering a CAGR of 7.18% during 2026–2035. Growth will be supported by outpatient migration, population aging, cancer screening and surveillance, chronic disease, musculoskeletal imaging demand, breast-imaging modernization, portable technology, and AI-enabled workflow improvement.

CT will remain the largest modality by value, while MRI, portable ultrasound, AI-enabled imaging, digital breast technologies, compact systems, and molecular imaging will generate attractive growth opportunities. Conventional X-ray and mature ultrasound platforms will continue to provide stable replacement demand because of their large installed bases and high examination volumes.

Independent imaging centers will remain the largest end-user group, but hospital-owned freestanding facilities, specialty practices, ambulatory surgery centers, and mobile providers will become increasingly important. The competitive advantage of each system will depend less on isolated technical specifications and more on total operating performance, including throughput, uptime, installation requirements, software capability, staffing efficiency, and service reliability.

The South will remain the largest regional market because of its population scale, older-adult growth, chronic disease burden, and expanding ambulatory infrastructure. The West will record the fastest growth through technology adoption, population movement, and decentralized care models. The Northeast will remain a premium, evidence-driven replacement market, while the Midwest will provide durable demand across established health systems and rural-access networks.

For manufacturers, imaging providers, investors, distributors, and healthcare systems evaluating this market, the central strategic issue is not whether diagnostic imaging will remain essential. The critical question is which technologies can deliver reliable clinical performance within the financial and operational constraints of outpatient care.

Companies that provide scalable systems, strong uptime, simplified siting, flexible financing, meaningful AI integration, enterprise connectivity, and demonstrable workflow improvement will be best positioned to capture growth during the next decade.

 

TABLE OF CONTENT

1. U.S. Outpatient Diagnostic Imaging Devices Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.2.1. Devices and Technologies Included
1.2.2. Outpatient Care Settings Included
1.2.3. Revenue Components Included
1.2.4. Market Exclusions
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Installed-Base and Replacement-Cycle Analysis
1.3.6. Average Selling Price and Service-Revenue Modeling
1.3.7. Analytical Frameworks & Forecasting Models
1.3.8. Data Triangulation, Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Diagnostic Imaging Device Manufacturers
1.6.2. Detector, Transducer, Coil and Imaging Component Suppliers
1.6.3. Independent Diagnostic Imaging Center Operators
1.6.4. Hospital Outpatient Departments and Freestanding Imaging Centers
1.6.5. Physician-Owned Imaging Practices and Specialty Clinics
1.6.6. Ambulatory Surgery Centers and Urgent Care Networks
1.6.7. Mobile, Rural and Community Imaging Providers
1.6.8. Imaging Informatics, AI and Cloud Platform Providers
1.6.9. Group Purchasing Organizations, Distributors and Financing Companies
1.6.10. Radiologists, Technologists and Clinical Decision-Makers
1.6.11. Commercial Payers, Medicare, Medicaid and Prior-Authorization Organizations
1.6.12. FDA, CMS, Accreditation Bodies and State Regulators

What this section provides: This section defines the outpatient diagnostic imaging device market boundary, study scope, revenue inclusions, methodology, assumptions and stakeholder ecosystem so clients understand how the U.S. market is measured, segmented and validated.

2. U.S. Outpatient Diagnostic Imaging Devices Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. Market Size and CAGR Summary
2.8. Leading Modality Analysis
2.9. Fastest-Growing Technology Analysis
2.10. Leading End-User Analysis
2.11. Regional Opportunity Summary
2.12. High-Growth Opportunity Areas
2.13. Key Strategic Findings for Market Participants

What this section provides: This section gives decision-makers a concise view of market size, forecast growth, modality mix, outpatient adoption, regional demand, competitive intensity and priority commercial opportunities.

3. U.S. Outpatient Diagnostic Imaging Devices Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Migration of Diagnostic Services Toward Lower-Cost Outpatient Settings
3.1.2. Expansion of Independent and Health-System-Owned Imaging Centers
3.1.3. Rising Cancer Screening, Staging and Surveillance Demand
3.1.4. Aging U.S. Population and Increasing Imaging Utilization
3.1.5. Growth in Musculoskeletal and Orthopedic Imaging Procedures
3.1.6. Expansion of Cardiovascular and Vascular Diagnostic Imaging
3.1.7. Increasing Adoption of Digital Breast Tomosynthesis
3.1.8. Growth in Portable and Point-of-Care Imaging
3.1.9. AI-Assisted Acquisition, Reconstruction and Workflow Automation
3.1.10. Replacement of Aging CT, MRI, X-Ray and Ultrasound Systems
3.1.11. Demand for Faster Scheduling and Consumer-Oriented Imaging Access
3.1.12. Growth of Multisite Radiology and Imaging Center Networks
3.2. Restraints and Their Impact Analysis
3.2.1. High Capital Cost of Advanced Imaging Systems
3.2.2. Commercial Payer Reimbursement and Prior-Authorization Pressure
3.2.3. Medicare Payment Reductions and Site-of-Service Economics
3.2.4. Radiologist and Imaging Technologist Workforce Shortages
3.2.5. High Facility Construction, Shielding and Installation Costs
3.2.6. Equipment Downtime and Service-Contract Expenses
3.2.7. Cybersecurity and Interoperability Requirements
3.2.8. Certificate-of-Need and State-Level Regulatory Restrictions
3.2.9. Refurbished Equipment Competition and Pricing Pressure
3.3. Opportunities and Their Impact Analysis
3.3.1. Photon-Counting and Spectral CT Adoption
3.3.2. Helium-Light, Wide-Bore and Compact MRI Expansion
3.3.3. AI-Enabled Imaging Workflow and Automated Measurements
3.3.4. Portable MRI, Handheld Ultrasound and Mobile Radiography
3.3.5. Contrast-Enhanced Mammography and Advanced Breast Imaging
3.3.6. Digital PET, SPECT/CT and Theranostic Imaging Expansion
3.3.7. Remote Scanning and Centralized Imaging Command Centers
3.3.8. Cloud-Native PACS and Enterprise Imaging Platforms
3.3.9. Rural, Mobile and Community Imaging Access
3.3.10. Managed-Equipment Services and Subscription-Based Procurement
3.3.11. Refurbishment, Software Upgrades and Installed-Base Modernization
3.4. Challenges and Their Impact Analysis
3.4.1. Balancing Clinical Performance with Outpatient Economics
3.4.2. Maintaining Scanner Utilization and Examination Throughput
3.4.3. Managing Modality-Specific Staffing Requirements
3.4.4. Achieving Consistent Quality Across Multisite Networks
3.4.5. Integrating AI Applications into Existing Workflows
3.4.6. Managing Equipment Obsolescence and Upgrade Cycles
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Outpatient Clinical Workflow Economics Analysis
3.6.1. Examination Throughput and Scanner Utilization
3.6.2. Revenue per Scanning Hour
3.6.3. Technologist Productivity and Staffing Cost
3.6.4. Retake, Cancellation and No-Show Economics
3.6.5. Equipment Uptime and Lost-Revenue Analysis
3.7. Outpatient Capital Procurement Behavior Analysis
3.7.1. Capital Budget Approval Criteria
3.7.2. Total Cost of Ownership Assessment
3.7.3. New Equipment Versus Refurbished Equipment Decisions
3.7.4. Purchase, Lease and Managed-Service Evaluation
3.7.5. Vendor Standardization Across Multisite Networks

What this section provides: This section explains the clinical, economic, reimbursement, operational and technological forces shaping outpatient imaging equipment demand, helping clients evaluate market upside, adoption barriers and execution risks.

4. U.S. Outpatient Diagnostic Imaging Devices Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Outpatient Imaging Buyers
4.2.3. Bargaining Power of Component and Technology Suppliers
4.2.4. Substitution and Alternative Diagnostic Risk
4.2.5. Competitive Rivalry
4.3. Equipment Pricing Trend Analysis by Region, 2025–2035
4.3.1. New Equipment Pricing
4.3.2. Refurbished Equipment Pricing
4.3.3. Software, Upgrade and Subscription Pricing
4.3.4. Maintenance and Service-Contract Pricing
4.4. Value Chain & Supply Chain Analysis
4.4.1. Imaging Component and Detector Suppliers
4.4.2. Original Equipment Manufacturers
4.4.3. Distributors and Third-Party Service Organizations
4.4.4. Imaging Facility Operators
4.4.5. Radiology Reading and Informatics Providers
4.4.6. Payers and Patients
4.5. Impact of Digitalization and Connected Imaging
4.6. Imaging AI Application & Innovation Landscape
4.7. FDA Regulatory Framework Analysis
4.7.1. Device Classification and Premarket Pathways
4.7.2. AI-Enabled Imaging Device Authorization
4.7.3. Radiation-Emitting Product Requirements
4.7.4. Post-Market Surveillance and Recall Management
4.8. CMS Reimbursement and Coverage Landscape
4.8.1. Medicare Physician Fee Schedule
4.8.2. Hospital Outpatient Prospective Payment System
4.8.3. Independent Diagnostic Testing Facility Requirements
4.8.4. Appropriate Use Criteria and Utilization Management
4.8.5. Advanced Diagnostic Imaging Accreditation Requirements
4.9. Mammography Quality Standards Act and Breast Imaging Compliance
4.10. Imaging Accreditation and Quality Assurance Landscape
4.11. Commercial Payer Prior-Authorization and Site-of-Care Policies
4.12. Import/Export Restrictions & Tariff Impact
4.13. Government Initiatives and Screening Programs
4.14. Environmental Sustainability and Imaging Equipment Energy Use
4.15. Impact of Escalating Geopolitical and Supply-Chain Tensions
4.16. Outpatient Value Analysis and Capital Committee Decision Framework

What this section provides: This section gives clients a complete view of the regulatory, reimbursement, pricing, quality, supply-chain, digitalization and procurement environment influencing outpatient diagnostic imaging equipment adoption.

5. U.S. Outpatient Diagnostic Imaging Devices Market – By Modality

5.1. Overview
5.1.1. Segment Share Analysis, By Modality, 2025 & 2035 (%)
5.1.2. Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
5.2. Computed Tomography Systems
5.2.1. Conventional Multislice CT Systems
5.2.2. High-Slice and Cardiac CT Systems
5.2.3. Spectral and Dual-Energy CT Systems
5.2.4. Photon-Counting CT Systems
5.2.5. Compact and Mobile CT Systems
5.3. Magnetic Resonance Imaging Systems
5.3.1. 1.5-T MRI Systems
5.3.2. 3-T MRI Systems
5.3.3. Low-Field and Mid-Field MRI Systems
5.3.4. Wide-Bore MRI Systems
5.3.5. Extremity and Dedicated MRI Systems
5.3.6. Portable and Compact MRI Systems
5.4. Ultrasound Imaging Systems
5.4.1. Cart-Based Ultrasound Systems
5.4.2. Compact Ultrasound Systems
5.4.3. Handheld Ultrasound Systems
5.4.4. Cardiovascular Ultrasound Systems
5.4.5. Women’s Health and Breast Ultrasound Systems
5.4.6. Musculoskeletal and General Imaging Ultrasound Systems
5.5. Digital X-Ray and Fluoroscopy Systems
5.5.1. Fixed Digital Radiography Systems
5.5.2. Mobile Digital Radiography Systems
5.5.3. Digital Radiography Detectors
5.5.4. Radiography-Fluoroscopy Systems
5.5.5. Mobile C-Arms
5.5.6. Cone-Beam CT and Specialty X-Ray Systems
5.6. Mammography and Breast Imaging Systems
5.6.1. Full-Field Digital Mammography Systems
5.6.2. Digital Breast Tomosynthesis Systems
5.6.3. Contrast-Enhanced Mammography Systems
5.6.4. Breast Biopsy and Stereotactic Guidance Systems
5.6.5. Automated Breast Ultrasound Systems
5.6.6. Dedicated Breast Imaging Technologies
5.7. Nuclear and Molecular Imaging Systems
5.7.1. PET Systems
5.7.2. PET/CT Systems
5.7.3. SPECT Systems
5.7.4. SPECT/CT Systems
5.7.5. Digital Molecular Imaging Systems
5.7.6. Mobile Nuclear Imaging Systems

What this section provides: This section identifies the imaging modalities and submodalities expected to generate the largest revenue contribution, strongest replacement demand and fastest technology-led growth through 2035.

6. U.S. Outpatient Diagnostic Imaging Devices Market – By Application

6.1. Overview
6.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)
6.1.2. Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
6.2. Oncology Imaging
6.2.1. Cancer Screening
6.2.2. Tumor Detection and Diagnosis
6.2.3. Cancer Staging
6.2.4. Treatment Response Assessment
6.2.5. Recurrence and Survivorship Surveillance
6.3. Musculoskeletal and Orthopedic Imaging
6.3.1. Spine Imaging
6.3.2. Joint and Extremity Imaging
6.3.3. Sports Injury Imaging
6.3.4. Trauma Follow-Up Imaging
6.3.5. Postoperative Orthopedic Imaging
6.4. Cardiovascular and Vascular Imaging
6.4.1. Echocardiography
6.4.2. Vascular Ultrasound
6.4.3. Coronary CT Angiography
6.4.4. Cardiac MRI
6.4.5. Nuclear Cardiology
6.5. Women’s Health Imaging
6.5.1. Breast Cancer Screening
6.5.2. Diagnostic Breast Imaging
6.5.3. Obstetric Imaging
6.5.4. Gynecological Imaging
6.5.5. Bone Health and Osteoporosis Imaging
6.6. Neurological Imaging
6.6.1. Brain Imaging
6.6.2. Spine and Nerve Imaging
6.6.3. Stroke and Cerebrovascular Imaging
6.6.4. Dementia and Neurodegenerative Disease Imaging
6.6.5. Multiple Sclerosis and Seizure Imaging
6.7. General, Abdominal, Pulmonary and Other Imaging
6.7.1. Abdominal and Gastrointestinal Imaging
6.7.2. Renal and Urological Imaging
6.7.3. Pulmonary and Lung Screening Imaging
6.7.4. Endocrine and Thyroid Imaging
6.7.5. General Diagnostic and Preventive Imaging

What this section provides: This section helps clients understand demand by clinical application and prioritize imaging use cases with strong procedure growth, recurring utilization, screening relevance and outpatient expansion potential.

7. U.S. Outpatient Diagnostic Imaging Devices Market – By End User

7.1. Overview
7.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
7.1.2. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
7.2. Independent Diagnostic Imaging Centers
7.2.1. Single-Site Independent Imaging Centers
7.2.2. Regional Multisite Imaging Networks
7.2.3. National Diagnostic Imaging Chains
7.2.4. Radiologist-Owned Imaging Centers
7.3. Hospital Outpatient Departments and Freestanding Health-System Centers
7.3.1. Hospital Campus Outpatient Imaging Departments
7.3.2. Freestanding Health-System Imaging Centers
7.3.3. Community and Satellite Imaging Facilities
7.3.4. Outpatient Oncology Imaging Centers
7.4. Physician Offices and Specialty Clinics
7.4.1. Orthopedic and Sports Medicine Practices
7.4.2. Cardiology and Vascular Practices
7.4.3. Women’s Health and Breast Care Centers
7.4.4. Neurology and Spine Practices
7.4.5. Urology, Gastroenterology and Multispecialty Clinics
7.5. Ambulatory Surgery Centers and Urgent Care Facilities
7.5.1. Multispecialty Ambulatory Surgery Centers
7.5.2. Orthopedic and Pain Management ASCs
7.5.3. Urgent Care Networks
7.5.4. Occupational Health and Employer-Based Clinics
7.6. Mobile, Rural, Retail and Community Imaging Providers
7.6.1. Mobile Radiography Providers
7.6.2. Mobile Mammography Providers
7.6.3. Mobile CT, MRI and Nuclear Imaging Providers
7.6.4. Rural and Community Diagnostic Facilities
7.6.5. Skilled Nursing and Home-Based Imaging Providers
7.6.6. Retail and Preventive Imaging Providers

What this section provides: This section explains which outpatient care settings and customer groups are expected to drive equipment purchasing, replacement activity, software adoption and recurring service demand.

8. U.S. Outpatient Diagnostic Imaging Devices Market – By Technology Configuration

8.1. Overview
8.1.1. Segment Share Analysis, By Technology Configuration, 2025 & 2035 (%)
8.1.2. Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
8.2. Fixed High-Capacity Imaging Systems
8.2.1. Premium Fixed Imaging Systems
8.2.2. High-Throughput Multimodality Systems
8.2.3. Dedicated Specialty Imaging Systems
8.3. Compact and Space-Efficient Imaging Systems
8.3.1. Compact MRI Systems
8.3.2. Compact CT Systems
8.3.3. Compact Ultrasound and X-Ray Systems
8.3.4. Extremity and Cone-Beam Imaging Systems
8.4. Mobile and Portable Imaging Devices
8.4.1. Portable X-Ray Systems
8.4.2. Handheld and Portable Ultrasound Systems
8.4.3. Mobile C-Arms
8.4.4. Mobile CT and MRI Systems
8.4.5. Mobile Mammography and Nuclear Imaging Systems
8.5. AI-Enabled and Software-Defined Imaging Platforms
8.5.1. AI-Assisted Image Acquisition
8.5.2. AI-Based Reconstruction and Image Enhancement
8.5.3. Computer-Aided Detection and Diagnosis
8.5.4. Automated Measurements and Quantification
8.5.5. Workflow Orchestration and Worklist Prioritization
8.5.6. Cloud PACS and Enterprise Imaging Platforms
8.5.7. Remote Scanning and Command-Center Technologies
8.6. Refurbished, Upgraded and Managed-Equipment Solutions
8.6.1. Refurbished Imaging Systems
8.6.2. Detector, Coil and Transducer Upgrades
8.6.3. Software and Clinical Application Upgrades
8.6.4. Managed-Equipment Services
8.6.5. Equipment-as-a-Service and Pay-per-Use Models

What this section provides: This section evaluates the system configurations shaping outpatient imaging, including fixed, compact, portable, AI-enabled, refurbished and managed-equipment solutions.

9. U.S. Outpatient Diagnostic Imaging Devices Market – By Procurement Model

9.1. Overview
9.1.1. Segment Share Analysis, By Procurement Model, 2025 & 2035 (%)
9.1.2. Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
9.2. Direct Manufacturer Procurement
9.2.1. Capital Equipment Purchase
9.2.2. Direct Service and Maintenance Contracts
9.2.3. Manufacturer Software and Upgrade Agreements
9.3. Health System and Integrated Delivery Network Enterprise Contracts
9.3.1. Multisite Equipment Standardization
9.3.2. Enterprise Service Agreements
9.3.3. Modality Fleet Management Contracts
9.3.4. Long-Term Strategic Vendor Partnerships
9.4. Group Purchasing Organization and Distributor Procurement
9.4.1. Group Purchasing Organization Contracts
9.4.2. Authorized Distributor Sales
9.4.3. Specialty Imaging Equipment Distributors
9.4.4. Third-Party Service Organization Contracts
9.5. Leasing, Financing and Managed-Equipment Procurement
9.5.1. Operating Leases
9.5.2. Capital Leases
9.5.3. Vendor Financing
9.5.4. Managed-Equipment Service Contracts
9.5.5. Subscription and Pay-per-Use Models
9.6. Refurbished and Secondary-Market Procurement
9.6.1. OEM-Certified Refurbished Systems
9.6.2. Independent Refurbished Equipment Suppliers
9.6.3. Used Equipment Resale and Brokerage
9.6.4. Trade-In and Equipment Replacement Programs

What this section provides: This section helps clients understand how outpatient imaging devices are purchased, financed, serviced and upgraded through direct contracts, enterprise agreements, distributors, leases and secondary-market channels.

10. U.S. Outpatient Diagnostic Imaging Devices Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Outpatient Imaging Procedure Volume Analysis
10.1.4. Regional Imaging Center and Installed-Base Analysis
10.1.5. Regional Reimbursement and Prior-Authorization Dynamics
10.1.6. Regional Capital Procurement and Replacement-Cycle Analysis
10.1.7. Regional Imaging Workforce and Access Analysis

10.2. West Region

10.2.1. Regional Overview & Trends
10.2.2. West Region Key Manufacturers, Imaging Operators and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.2.9. California
10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.2.10. Washington
10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.2.11. Arizona
10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.2.12. Colorado
10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.2.13. Oregon
10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.2.14. Utah
10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.2.15. Nevada
10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.2.16. New Mexico
10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.2.17. Idaho
10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.2.18. Montana
10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.2.19. Wyoming
10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.2.20. Alaska
10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.2.21. Hawaii
10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.3. Northeast Region

10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Key Manufacturers, Imaging Operators and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.3.9. New York
10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.3.10. Massachusetts
10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.3.11. New Jersey
10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.3.12. Pennsylvania
10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.3.13. Connecticut
10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.3.14. Maine
10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.3.15. Vermont
10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.3.16. New Hampshire
10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.3.17. Rhode Island
10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.4. South Region

10.4.1. Regional Overview & Trends
10.4.2. South Region Key Manufacturers, Imaging Operators and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.4.9. Texas
10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.4.10. Florida
10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.4.11. Georgia
10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.4.12. North Carolina
10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.4.13. Tennessee
10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.4.14. South Carolina
10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.4.15. Alabama
10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.4.16. Mississippi
10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.4.17. Louisiana
10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.4.18. Arkansas
10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.4.19. Kentucky
10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.4.20. Oklahoma
10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.4.21. Virginia
10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.4.22. Maryland
10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.4.23. West Virginia
10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.4.24. Delaware
10.4.24.1. Overview
10.4.24.2. Delaware Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.24.3. Delaware Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.24.4. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.24.5. Delaware Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.4.24.6. Delaware Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.4.25. District of Columbia
10.4.25.1. Overview
10.4.25.2. District of Columbia Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.25.3. District of Columbia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.25.4. District of Columbia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.25.5. District of Columbia Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.4.25.6. District of Columbia Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.5. Midwest Region

10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Key Manufacturers, Imaging Operators and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.5.9. Illinois
10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.5.10. Ohio
10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.5.11. Michigan
10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.5.12. Minnesota
10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.5.13. Indiana
10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.5.14. Wisconsin
10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.5.15. Missouri
10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.5.16. Iowa
10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.5.17. Kansas
10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.5.18. Nebraska
10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.5.19. North Dakota
10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

10.5.20. South Dakota
10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By Technology Configuration, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)

What this section provides: This section delivers detailed regional, state and District of Columbia analysis, helping clients identify priority outpatient imaging markets, installed-base concentrations, procedure-volume hubs, technology-adoption hotspots and state-level commercial opportunities.

11. U.S. Outpatient Diagnostic Imaging Devices Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.1.1. Market Share by Modality
11.1.2. Market Share by Outpatient Installed Base
11.1.3. Market Share by Service and Software Revenue
11.2. Company Positioning Matrix
11.2.1. Market Leaders
11.2.2. Established Challengers
11.2.3. Technology Innovators
11.2.4. Emerging and Specialized Players
11.3. Competitive Benchmarking
11.3.1. Product Portfolio Breadth
11.3.2. Outpatient System Positioning
11.3.3. U.S. Installed Base
11.3.4. Service and Maintenance Capabilities
11.3.5. AI and Imaging Informatics Capabilities
11.3.6. Financing and Managed-Equipment Offerings
11.3.7. Distribution and Channel Strength
11.4. Company Profiles
11.4.1. GE HealthCare
11.4.2. Siemens Healthineers
11.4.3. Philips Healthcare
11.4.4. Canon Medical Systems USA
11.4.5. FUJIFILM Healthcare Americas
11.4.6. Hologic
11.4.7. Carestream Health
11.4.8. Samsung Healthcare
11.4.9. United Imaging Healthcare America
11.4.10. Konica Minolta Healthcare Americas
11.4.11. Esaote North America
11.4.12. Agfa HealthCare
11.4.13. Shimadzu Medical Systems USA
11.4.14. Ziehm Imaging
11.4.15. Mindray North America
11.4.16. Butterfly Network
11.4.17. Hyperfine
11.4.18. CurveBeam AI
11.4.19. Delphinus Medical Technologies
11.4.20. Planmed USA
11.4.21. NeuroLogica
11.4.22. Sectra
11.4.23. Intelerad
11.4.24. Nano-X Imaging
11.4.25. Clarius Mobile Health

Note: Each company profile will include company overview, outpatient diagnostic imaging portfolio, U.S. market strategy, modality positioning, financial and operational positioning, AI and software capabilities, regulatory updates, partnerships, product launches, acquisitions and recent developments.

What this section provides: This section gives clients competitor benchmarking, market-share visibility, portfolio positioning, outpatient strategy, technology direction and strategic intelligence on leading diagnostic imaging companies.

12. U.S. Outpatient Diagnostic Imaging Devices Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. Photon-Counting and Advanced Spectral CT
12.2.2. Helium-Light, Low-Field and Portable MRI
12.2.3. AI-Based Reconstruction and Automated Acquisition
12.2.4. Handheld Ultrasound and Distributed Point-of-Care Imaging
12.2.5. Digital PET and Advanced Molecular Imaging
12.2.6. Contrast-Enhanced Mammography and AI-Based Breast Imaging
12.2.7. Cloud-Native Enterprise Imaging
12.2.8. Remote Scanning and Imaging Command Centers
12.2.9. Predictive Maintenance and Digital Twin Technologies
12.3. Emerging Business Trends
12.3.1. Consolidation of Independent Imaging Networks
12.3.2. Growth of Health-System Freestanding Imaging Centers
12.3.3. Equipment-as-a-Service Models
12.3.4. Increased Use of Refurbished and Upgraded Systems
12.3.5. Consumer-Oriented Scheduling and Price Transparency
12.3.6. Imaging Workforce Centralization
12.4. Business Opportunities for Startups and Existing Players
12.5. Investment Prioritization Matrix
12.6. Technology Adoption Timeline, 2026–2035
12.7. Modality Replacement-Cycle Outlook
12.8. Potential Market Disruption and Risk Factors

What this section provides: This section prepares clients for future technology shifts, equipment replacement cycles, market-structure changes, emerging business models and potential adoption scenarios through 2035.

13. U.S. Outpatient Diagnostic Imaging Devices Market: Strategic Recommendations

13.1. Recommendations for Diagnostic Imaging Device Manufacturers
13.2. Recommendations for Independent Imaging Center Operators
13.3. Recommendations for Hospitals and Integrated Health Systems
13.4. Recommendations for Physician Practices and Specialty Clinics
13.5. Recommendations for Investors and Private Equity Firms
13.6. Recommendations for Distributors and Channel Partners
13.7. Recommendations for Imaging Software and AI Companies
13.8. Recommendations for New Entrants and Startups
13.9. Go-to-Market Strategy Considerations
13.9.1. Target Customer Prioritization
13.9.2. Regional Market Entry Strategy
13.9.3. Clinical Evidence and Economic Value Positioning
13.9.4. Financing and Procurement Strategy
13.9.5. Service and Customer-Support Strategy
13.10. Product Positioning and Portfolio Expansion Guidance
13.11. Partnership, Acquisition and Channel Development Opportunities
13.12. Pricing, Contracting and Lifecycle Revenue Strategy

What this section provides: This section converts market intelligence into actionable strategy for product development, outpatient positioning, market entry, channel expansion, investment decisions and competitive differentiation.

14. U.S. Outpatient Diagnostic Imaging Devices Market: Disclaimer

14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Market Sizing and Forecasting Limitation
14.4. State-Level Estimation Limitation
14.5. Regulatory and Reimbursement Limitation
14.6. Legal Disclaimer
14.7. Third-Party Data Disclaimer
14.8. Forward-Looking Statements Disclaimer

What this section provides: This section clarifies the report’s scope limitations, legal boundaries, data-use conditions, state-level estimation methodology and forecasting assumptions.

 

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Outpatient Diagnostic Imaging Devices Market: Market Definition and Scope
TABLE 3: U.S. Outpatient Diagnostic Imaging Devices Market: Devices, Care Settings, Revenue Components and Market Exclusions
TABLE 4: U.S. Outpatient Diagnostic Imaging Devices Market: Research Methodology Framework
TABLE 5: U.S. Outpatient Diagnostic Imaging Devices Market: Installed-Base, Replacement-Cycle and Average Selling Price Methodology
TABLE 6: U.S. Outpatient Diagnostic Imaging Devices Market: Key Assumptions
TABLE 7: U.S. Outpatient Diagnostic Imaging Devices Market: Market Ecosystem Overview
TABLE 8: U.S. Outpatient Diagnostic Imaging Devices Market: Stakeholder Analysis
TABLE 9: U.S. Outpatient Diagnostic Imaging Devices Market: Executive Summary Snapshot, 2025
TABLE 10: U.S. Outpatient Diagnostic Imaging Devices Market: Analyst Viewpoint Summary
TABLE 11: U.S. Outpatient Diagnostic Imaging Devices Market: Market Attractiveness Index
TABLE 12: U.S. Outpatient Diagnostic Imaging Devices Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 13: U.S. Outpatient Diagnostic Imaging Devices Market: Base Year Market Positioning, 2025 (US$ Billion)
TABLE 14: U.S. Outpatient Diagnostic Imaging Devices Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 15: U.S. Outpatient Diagnostic Imaging Devices Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 16: U.S. Outpatient Diagnostic Imaging Devices Market: Leading Modality, Technology, End-User and Regional Opportunity Summary
TABLE 17: U.S. Outpatient Diagnostic Imaging Devices Market: Drivers; Impact Analysis
TABLE 18: U.S. Outpatient Diagnostic Imaging Devices Market: Restraints; Impact Analysis
TABLE 19: U.S. Outpatient Diagnostic Imaging Devices Market: Opportunities; Impact Analysis
TABLE 20: U.S. Outpatient Diagnostic Imaging Devices Market: Challenges; Impact Analysis
TABLE 21: U.S. Outpatient Diagnostic Imaging Devices Market: Patent & Innovation Analysis, 2021–2025
TABLE 22: U.S. Outpatient Diagnostic Imaging Devices Market: Outpatient Clinical Workflow Economics Matrix
TABLE 23: U.S. Outpatient Diagnostic Imaging Devices Market: Scanner Utilization, Throughput and Revenue per Scanning Hour Analysis
TABLE 24: U.S. Outpatient Diagnostic Imaging Devices Market: Outpatient Capital Procurement Behavior Matrix
TABLE 25: U.S. Outpatient Diagnostic Imaging Devices Market: New Equipment versus Refurbished Equipment Decision Matrix
TABLE 26: U.S. Outpatient Diagnostic Imaging Devices Market: Purchase, Lease and Managed-Service Evaluation
TABLE 27: U.S. Outpatient Diagnostic Imaging Devices Market: PESTEL Analysis
TABLE 28: U.S. Outpatient Diagnostic Imaging Devices Market: Porter’s Five Forces Analysis
TABLE 29: U.S. Outpatient Diagnostic Imaging Devices Market: Equipment Pricing Trend Analysis by Region, 2025–2035
TABLE 30: U.S. Outpatient Diagnostic Imaging Devices Market: Value Chain Analysis
TABLE 31: U.S. Outpatient Diagnostic Imaging Devices Market: Supply Chain Analysis
TABLE 32: U.S. Outpatient Diagnostic Imaging Devices Market: Digitalization and Connected Imaging Impact
TABLE 33: U.S. Outpatient Diagnostic Imaging Devices Market: Imaging AI Application & Innovation Landscape
TABLE 34: U.S. Outpatient Diagnostic Imaging Devices Market: FDA Regulatory Framework Analysis
TABLE 35: U.S. Outpatient Diagnostic Imaging Devices Market: CMS Reimbursement and Coverage Landscape
TABLE 36: U.S. Outpatient Diagnostic Imaging Devices Market: Mammography Quality Standards Act Compliance Landscape
TABLE 37: U.S. Outpatient Diagnostic Imaging Devices Market: Imaging Accreditation and Quality Assurance Landscape
TABLE 38: U.S. Outpatient Diagnostic Imaging Devices Market: Commercial Payer Prior-Authorization and Site-of-Care Policies
TABLE 39: U.S. Outpatient Diagnostic Imaging Devices Market: Import/Export Restrictions & Tariff Impact
TABLE 40: U.S. Outpatient Diagnostic Imaging Devices Market: Government Initiatives and Screening Programs
TABLE 41: U.S. Outpatient Diagnostic Imaging Devices Market: Environmental Sustainability and Imaging Equipment Energy Use
TABLE 42: U.S. Outpatient Diagnostic Imaging Devices Market: Impact of Escalating Geopolitical and Supply-Chain Tensions
TABLE 43: U.S. Outpatient Diagnostic Imaging Devices Market: Outpatient Value Analysis and Capital Committee Decision Framework
TABLE 44: U.S. Outpatient Diagnostic Imaging Devices Market: Modality Snapshot, 2025
TABLE 45: Segment Dashboard; Definition and Scope, by Modality
TABLE 46: U.S. Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 47: U.S. Outpatient Diagnostic Imaging Devices Market: Segment Share Analysis, by Modality, 2025 & 2035 (%)
TABLE 48: U.S. Outpatient Diagnostic Imaging Devices Market: Computed Tomography Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 49: U.S. Outpatient Diagnostic Imaging Devices Market: Magnetic Resonance Imaging Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 50: U.S. Outpatient Diagnostic Imaging Devices Market: Ultrasound Imaging Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 51: U.S. Outpatient Diagnostic Imaging Devices Market: Digital X-Ray and Fluoroscopy Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 52: U.S. Outpatient Diagnostic Imaging Devices Market: Mammography and Breast Imaging Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 53: U.S. Outpatient Diagnostic Imaging Devices Market: Nuclear and Molecular Imaging Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 54: U.S. Outpatient Diagnostic Imaging Devices Market: Application Snapshot, 2025
TABLE 55: Segment Dashboard; Definition and Scope, by Application
TABLE 56: U.S. Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 57: U.S. Outpatient Diagnostic Imaging Devices Market: Segment Share Analysis, by Application, 2025 & 2035 (%)
TABLE 58: U.S. Outpatient Diagnostic Imaging Devices Market: Oncology Imaging Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 59: U.S. Outpatient Diagnostic Imaging Devices Market: Musculoskeletal and Orthopedic Imaging Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 60: U.S. Outpatient Diagnostic Imaging Devices Market: Cardiovascular and Vascular Imaging Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 61: U.S. Outpatient Diagnostic Imaging Devices Market: Women’s Health Imaging Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 62: U.S. Outpatient Diagnostic Imaging Devices Market: Neurological Imaging Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 63: U.S. Outpatient Diagnostic Imaging Devices Market: General, Abdominal, Pulmonary and Other Imaging Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 64: U.S. Outpatient Diagnostic Imaging Devices Market: End User Snapshot, 2025
TABLE 65: Segment Dashboard; Definition and Scope, by End User
TABLE 66: U.S. Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 67: U.S. Outpatient Diagnostic Imaging Devices Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 68: U.S. Outpatient Diagnostic Imaging Devices Market: Independent Diagnostic Imaging Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 69: U.S. Outpatient Diagnostic Imaging Devices Market: Hospital Outpatient Departments and Freestanding Health-System Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 70: U.S. Outpatient Diagnostic Imaging Devices Market: Physician Offices and Specialty Clinics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 71: U.S. Outpatient Diagnostic Imaging Devices Market: Ambulatory Surgery Centers and Urgent Care Facilities Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 72: U.S. Outpatient Diagnostic Imaging Devices Market: Mobile, Rural, Retail and Community Imaging Providers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 73: U.S. Outpatient Diagnostic Imaging Devices Market: Technology Configuration Snapshot, 2025
TABLE 74: Segment Dashboard; Definition and Scope, by Technology Configuration
TABLE 75: U.S. Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 76: U.S. Outpatient Diagnostic Imaging Devices Market: Segment Share Analysis, by Technology Configuration, 2025 & 2035 (%)
TABLE 77: U.S. Outpatient Diagnostic Imaging Devices Market: Fixed High-Capacity Imaging Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 78: U.S. Outpatient Diagnostic Imaging Devices Market: Compact and Space-Efficient Imaging Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 79: U.S. Outpatient Diagnostic Imaging Devices Market: Mobile and Portable Imaging Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 80: U.S. Outpatient Diagnostic Imaging Devices Market: AI-Enabled and Software-Defined Imaging Platforms Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 81: U.S. Outpatient Diagnostic Imaging Devices Market: Refurbished, Upgraded and Managed-Equipment Solutions Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 82: U.S. Outpatient Diagnostic Imaging Devices Market: Procurement Model Snapshot, 2025
TABLE 83: Segment Dashboard; Definition and Scope, by Procurement Model
TABLE 84: U.S. Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 85: U.S. Outpatient Diagnostic Imaging Devices Market: Segment Share Analysis, by Procurement Model, 2025 & 2035 (%)
TABLE 86: U.S. Outpatient Diagnostic Imaging Devices Market: Direct Manufacturer Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 87: U.S. Outpatient Diagnostic Imaging Devices Market: Health System and Integrated Delivery Network Enterprise Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 88: U.S. Outpatient Diagnostic Imaging Devices Market: Group Purchasing Organization and Distributor Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 89: U.S. Outpatient Diagnostic Imaging Devices Market: Leasing, Financing and Managed-Equipment Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 90: U.S. Outpatient Diagnostic Imaging Devices Market: Refurbished and Secondary-Market Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 91: U.S. Outpatient Diagnostic Imaging Devices Market: Regional Snapshot, 2025
TABLE 92: Segment Dashboard; Definition and Scope, by Geography
TABLE 93: U.S. Outpatient Diagnostic Imaging Devices Market, by Geography, 2021–2035 (US$ Billion)
TABLE 94: U.S. Outpatient Diagnostic Imaging Devices Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 95: West Region U.S. Outpatient Diagnostic Imaging Devices Market: Regional Overview and Trends
TABLE 96: West Region U.S. Outpatient Diagnostic Imaging Devices Market: Key Manufacturers, Imaging Operators and Procurement Ecosystem
TABLE 97: West Region U.S. Outpatient Diagnostic Imaging Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 98: West Region U.S. Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 99: West Region U.S. Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 100: West Region U.S. Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 101: West Region U.S. Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 102: West Region U.S. Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 103: California Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 104: California Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 105: California Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 106: California Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 107: California Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 108: Washington Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 109: Washington Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 110: Washington Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 111: Washington Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 112: Washington Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 113: Arizona Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 114: Arizona Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 115: Arizona Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 116: Arizona Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 117: Arizona Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 118: Colorado Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 119: Colorado Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 120: Colorado Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 121: Colorado Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 122: Colorado Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 123: Oregon Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 124: Oregon Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 125: Oregon Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 126: Oregon Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 127: Oregon Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 128: Utah Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 129: Utah Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 130: Utah Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 131: Utah Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 132: Utah Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 133: Nevada Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 134: Nevada Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 135: Nevada Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 136: Nevada Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 137: Nevada Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 138: New Mexico Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 139: New Mexico Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 140: New Mexico Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 141: New Mexico Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 142: New Mexico Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 143: Idaho Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 144: Idaho Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 145: Idaho Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 146: Idaho Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 147: Idaho Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 148: Montana Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 149: Montana Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 150: Montana Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 151: Montana Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 152: Montana Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 153: Wyoming Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 154: Wyoming Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 155: Wyoming Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 156: Wyoming Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 157: Wyoming Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 158: Alaska Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 159: Alaska Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 160: Alaska Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 161: Alaska Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 162: Alaska Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 163: Hawaii Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 164: Hawaii Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 165: Hawaii Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 166: Hawaii Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 167: Hawaii Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 168: Northeast Region U.S. Outpatient Diagnostic Imaging Devices Market: Regional Overview and Trends
TABLE 169: Northeast Region U.S. Outpatient Diagnostic Imaging Devices Market: Key Manufacturers, Imaging Operators and Procurement Ecosystem
TABLE 170: Northeast Region U.S. Outpatient Diagnostic Imaging Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 171: Northeast Region U.S. Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 172: Northeast Region U.S. Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 173: Northeast Region U.S. Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 174: Northeast Region U.S. Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 175: Northeast Region U.S. Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 176: New York Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 177: New York Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 178: New York Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 179: New York Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 180: New York Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 181: Massachusetts Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 182: Massachusetts Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 183: Massachusetts Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 184: Massachusetts Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 185: Massachusetts Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 186: New Jersey Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 187: New Jersey Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 188: New Jersey Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 189: New Jersey Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 190: New Jersey Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 191: Pennsylvania Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 192: Pennsylvania Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 193: Pennsylvania Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 194: Pennsylvania Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 195: Pennsylvania Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 196: Connecticut Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 197: Connecticut Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 198: Connecticut Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 199: Connecticut Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 200: Connecticut Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 201: Maine Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 202: Maine Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 203: Maine Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 204: Maine Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 205: Maine Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 206: Vermont Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 207: Vermont Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 208: Vermont Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 209: Vermont Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 210: Vermont Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 211: New Hampshire Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 212: New Hampshire Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 213: New Hampshire Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 214: New Hampshire Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 215: New Hampshire Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 216: Rhode Island Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 217: Rhode Island Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 218: Rhode Island Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 219: Rhode Island Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 220: Rhode Island Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 221: South Region U.S. Outpatient Diagnostic Imaging Devices Market: Regional Overview and Trends
TABLE 222: South Region U.S. Outpatient Diagnostic Imaging Devices Market: Key Manufacturers, Imaging Operators and Procurement Ecosystem
TABLE 223: South Region U.S. Outpatient Diagnostic Imaging Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 224: South Region U.S. Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 225: South Region U.S. Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 226: South Region U.S. Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 227: South Region U.S. Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 228: South Region U.S. Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 229: Texas Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 230: Texas Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 231: Texas Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 232: Texas Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 233: Texas Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 234: Florida Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 235: Florida Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 236: Florida Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 237: Florida Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 238: Florida Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 239: Georgia Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 240: Georgia Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 241: Georgia Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 242: Georgia Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 243: Georgia Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 244: North Carolina Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 245: North Carolina Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 246: North Carolina Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 247: North Carolina Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 248: North Carolina Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 249: Tennessee Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 250: Tennessee Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 251: Tennessee Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 252: Tennessee Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 253: Tennessee Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 254: South Carolina Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 255: South Carolina Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 256: South Carolina Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 257: South Carolina Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 258: South Carolina Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 259: Alabama Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 260: Alabama Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 261: Alabama Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 262: Alabama Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 263: Alabama Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 264: Mississippi Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 265: Mississippi Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 266: Mississippi Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 267: Mississippi Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 268: Mississippi Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 269: Louisiana Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 270: Louisiana Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 271: Louisiana Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 272: Louisiana Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 273: Louisiana Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 274: Arkansas Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 275: Arkansas Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 276: Arkansas Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 277: Arkansas Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 278: Arkansas Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 279: Kentucky Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 280: Kentucky Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 281: Kentucky Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 282: Kentucky Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 283: Kentucky Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 284: Oklahoma Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 285: Oklahoma Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 286: Oklahoma Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 287: Oklahoma Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 288: Oklahoma Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 289: Virginia Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 290: Virginia Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 291: Virginia Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 292: Virginia Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 293: Virginia Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 294: Maryland Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 295: Maryland Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 296: Maryland Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 297: Maryland Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 298: Maryland Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 299: West Virginia Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 300: West Virginia Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 301: West Virginia Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 302: West Virginia Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 303: West Virginia Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 304: Delaware Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 305: Delaware Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 306: Delaware Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 307: Delaware Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 308: Delaware Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 309: District of Columbia Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 310: District of Columbia Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 311: District of Columbia Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 312: District of Columbia Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 313: District of Columbia Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 314: Midwest Region U.S. Outpatient Diagnostic Imaging Devices Market: Regional Overview and Trends
TABLE 315: Midwest Region U.S. Outpatient Diagnostic Imaging Devices Market: Key Manufacturers, Imaging Operators and Procurement Ecosystem
TABLE 316: Midwest Region U.S. Outpatient Diagnostic Imaging Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 317: Midwest Region U.S. Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 318: Midwest Region U.S. Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 319: Midwest Region U.S. Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 320: Midwest Region U.S. Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 321: Midwest Region U.S. Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 322: Illinois Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 323: Illinois Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 324: Illinois Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 325: Illinois Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 326: Illinois Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 327: Ohio Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 328: Ohio Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 329: Ohio Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 330: Ohio Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 331: Ohio Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 332: Michigan Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 333: Michigan Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 334: Michigan Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 335: Michigan Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 336: Michigan Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 337: Minnesota Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 338: Minnesota Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 339: Minnesota Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 340: Minnesota Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 341: Minnesota Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 342: Indiana Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 343: Indiana Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 344: Indiana Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 345: Indiana Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 346: Indiana Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 347: Wisconsin Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 348: Wisconsin Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 349: Wisconsin Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 350: Wisconsin Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 351: Wisconsin Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 352: Missouri Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 353: Missouri Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 354: Missouri Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 355: Missouri Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 356: Missouri Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 357: Iowa Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 358: Iowa Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 359: Iowa Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 360: Iowa Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 361: Iowa Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 362: Kansas Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 363: Kansas Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 364: Kansas Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 365: Kansas Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 366: Kansas Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 367: Nebraska Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 368: Nebraska Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 369: Nebraska Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 370: Nebraska Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 371: Nebraska Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 372: North Dakota Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 373: North Dakota Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 374: North Dakota Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 375: North Dakota Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 376: North Dakota Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 377: South Dakota Outpatient Diagnostic Imaging Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 378: South Dakota Outpatient Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 379: South Dakota Outpatient Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 380: South Dakota Outpatient Diagnostic Imaging Devices Market, by Technology Configuration, 2021–2035 (US$ Billion)
TABLE 381: South Dakota Outpatient Diagnostic Imaging Devices Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 382: U.S. Outpatient Diagnostic Imaging Devices Market: Competitive Landscape Snapshot, 2025
TABLE 383: U.S. Outpatient Diagnostic Imaging Devices Market: Key Company Market Share Analysis, 2025
TABLE 384: U.S. Outpatient Diagnostic Imaging Devices Market: Company Positioning Matrix
TABLE 385: U.S. Outpatient Diagnostic Imaging Devices Market: Competitive Benchmarking by Portfolio, Installed Base, Service and AI Capability
TABLE 386: U.S. Outpatient Diagnostic Imaging Devices Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 387: GE HealthCare: Company Profile
TABLE 388: Siemens Healthineers: Company Profile
TABLE 389: Philips Healthcare: Company Profile
TABLE 390: Canon Medical Systems USA: Company Profile
TABLE 391: FUJIFILM Healthcare Americas: Company Profile
TABLE 392: Hologic: Company Profile
TABLE 393: Carestream Health: Company Profile
TABLE 394: Samsung Healthcare: Company Profile
TABLE 395: United Imaging Healthcare America: Company Profile
TABLE 396: Konica Minolta Healthcare Americas: Company Profile
TABLE 397: Esaote North America: Company Profile
TABLE 398: Agfa HealthCare: Company Profile
TABLE 399: Shimadzu Medical Systems USA: Company Profile
TABLE 400: Ziehm Imaging: Company Profile
TABLE 401: Mindray North America: Company Profile
TABLE 402: Butterfly Network: Company Profile
TABLE 403: Hyperfine: Company Profile
TABLE 404: CurveBeam AI: Company Profile
TABLE 405: Delphinus Medical Technologies: Company Profile
TABLE 406: Planmed USA: Company Profile
TABLE 407: NeuroLogica: Company Profile
TABLE 408: Sectra: Company Profile
TABLE 409: Intelerad: Company Profile
TABLE 410: Nano-X Imaging: Company Profile
TABLE 411: Clarius Mobile Health: Company Profile
TABLE 412: U.S. Outpatient Diagnostic Imaging Devices Market: Future Market Scenario Analysis, 2026–2035
TABLE 413: U.S. Outpatient Diagnostic Imaging Devices Market: Disruptive Technologies Impact Matrix
TABLE 414: U.S. Outpatient Diagnostic Imaging Devices Market: Emerging Business Trends
TABLE 415: U.S. Outpatient Diagnostic Imaging Devices Market: Business Opportunities for Startups and Existing Players
TABLE 416: U.S. Outpatient Diagnostic Imaging Devices Market: Investment Prioritization Matrix
TABLE 417: U.S. Outpatient Diagnostic Imaging Devices Market: Technology Adoption Timeline, 2026–2035
TABLE 418: U.S. Outpatient Diagnostic Imaging Devices Market: Modality Replacement-Cycle Outlook
TABLE 419: U.S. Outpatient Diagnostic Imaging Devices Market: Potential Market Disruption and Risk Factors
TABLE 420: U.S. Outpatient Diagnostic Imaging Devices Market: Strategic Recommendations for Diagnostic Imaging Device Manufacturers
TABLE 421: U.S. Outpatient Diagnostic Imaging Devices Market: Strategic Recommendations for Independent Imaging Center Operators
TABLE 422: U.S. Outpatient Diagnostic Imaging Devices Market: Strategic Recommendations for Hospitals and Integrated Health Systems
TABLE 423: U.S. Outpatient Diagnostic Imaging Devices Market: Strategic Recommendations for Physician Practices and Specialty Clinics
TABLE 424: U.S. Outpatient Diagnostic Imaging Devices Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 425: U.S. Outpatient Diagnostic Imaging Devices Market: Strategic Recommendations for Distributors and Channel Partners
TABLE 426: U.S. Outpatient Diagnostic Imaging Devices Market: Strategic Recommendations for Imaging Software and AI Companies
TABLE 427: U.S. Outpatient Diagnostic Imaging Devices Market: Strategic Recommendations for New Entrants and Startups
TABLE 428: U.S. Outpatient Diagnostic Imaging Devices Market: Go-to-Market Strategy Considerations
TABLE 429: U.S. Outpatient Diagnostic Imaging Devices Market: Product Positioning and Portfolio Expansion Guidance
TABLE 430: U.S. Outpatient Diagnostic Imaging Devices Market: Partnership, Acquisition and Channel Development Opportunities
TABLE 431: U.S. Outpatient Diagnostic Imaging Devices Market: Pricing, Contracting and Lifecycle Revenue Strategy
TABLE 432: U.S. Outpatient Diagnostic Imaging Devices Market: Scope Limitation
TABLE 433: U.S. Outpatient Diagnostic Imaging Devices Market: Data Use Limitation
TABLE 434: U.S. Outpatient Diagnostic Imaging Devices Market: Market Sizing and Forecasting Limitation
TABLE 435: U.S. Outpatient Diagnostic Imaging Devices Market: State-Level Estimation Limitation
TABLE 436: U.S. Outpatient Diagnostic Imaging Devices Market: Regulatory and Reimbursement Limitation
TABLE 437: U.S. Outpatient Diagnostic Imaging Devices Market: Legal Disclaimer
TABLE 438: U.S. Outpatient Diagnostic Imaging Devices Market: Third-Party Data Disclaimer
TABLE 439: U.S. Outpatient Diagnostic Imaging Devices Market: Forward-Looking Statements Disclaimer

List of Figures

FIGURE 1: U.S. Outpatient Diagnostic Imaging Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Installed-Base, Replacement-Cycle and Average Selling Price Modeling Framework
FIGURE 4: Value Chain Analysis
FIGURE 5: Supply Chain Analysis
FIGURE 6: PESTEL Analysis
FIGURE 7: Porter’s Five Forces Analysis
FIGURE 8: Market Attractiveness Analysis
FIGURE 9: Market Dynamics
FIGURE 10: Innovation & Patent Landscape, 2021–2025
FIGURE 11: Outpatient Clinical Workflow Economics Framework
FIGURE 12: Scanner Utilization and Revenue per Scanning Hour Framework
FIGURE 13: Outpatient Capital Procurement Decision Framework
FIGURE 14: U.S. Outpatient Diagnostic Imaging Devices Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 15: U.S. Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 16: U.S. Outpatient Diagnostic Imaging Devices Market Year-wise Growth Curve, 2021–2035
FIGURE 17: Modality Segment Market Share Analysis, 2025 & 2035
FIGURE 18: Modality Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 19: Computed Tomography Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 20: Magnetic Resonance Imaging Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 21: Ultrasound Imaging Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 22: Digital X-Ray and Fluoroscopy Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 23: Mammography and Breast Imaging Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 24: Nuclear and Molecular Imaging Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 25: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 26: Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 27: Oncology Imaging Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 28: Musculoskeletal and Orthopedic Imaging Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 29: Cardiovascular and Vascular Imaging Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 30: Women’s Health Imaging Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 31: Neurological Imaging Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 32: General, Abdominal, Pulmonary and Other Imaging Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 33: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 34: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 35: Independent Diagnostic Imaging Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: Hospital Outpatient Departments and Freestanding Health-System Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 37: Physician Offices and Specialty Clinics Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 38: Ambulatory Surgery Centers and Urgent Care Facilities Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 39: Mobile, Rural, Retail and Community Imaging Providers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 40: Technology Configuration Segment Market Share Analysis, 2025 & 2035
FIGURE 41: Technology Configuration Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 42: Fixed High-Capacity Imaging Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 43: Compact and Space-Efficient Imaging Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 44: Mobile and Portable Imaging Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 45: AI-Enabled and Software-Defined Imaging Platforms Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 46: Refurbished, Upgraded and Managed-Equipment Solutions Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 47: Procurement Model Segment Market Share Analysis, 2025 & 2035
FIGURE 48: Procurement Model Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 49: Direct Manufacturer Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 50: Health System and Integrated Delivery Network Enterprise Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 51: Group Purchasing Organization and Distributor Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 52: Leasing, Financing and Managed-Equipment Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 53: Refurbished and Secondary-Market Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 54: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 55: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 56: West Region U.S. Outpatient Diagnostic Imaging Devices Market Share and Leading Players, 2025
FIGURE 57: West Region Market Share Analysis by State, 2025
FIGURE 58: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 59: California Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 60: Washington Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 61: Arizona Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 62: Colorado Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 63: Oregon Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 64: Utah Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 65: Nevada Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 66: New Mexico Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 67: Idaho Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 68: Montana Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 69: Wyoming Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 70: Alaska Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 71: Hawaii Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 72: Northeast Region U.S. Outpatient Diagnostic Imaging Devices Market Share and Leading Players, 2025
FIGURE 73: Northeast Region Market Share Analysis by State, 2025
FIGURE 74: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 75: New York Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 76: Massachusetts Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 77: New Jersey Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 78: Pennsylvania Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 79: Connecticut Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: Maine Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 81: Vermont Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 82: New Hampshire Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 83: Rhode Island Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 84: South Region U.S. Outpatient Diagnostic Imaging Devices Market Share and Leading Players, 2025
FIGURE 85: South Region Market Share Analysis by State, 2025
FIGURE 86: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 87: Texas Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 88: Florida Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 89: Georgia Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 90: North Carolina Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 91: Tennessee Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 92: South Carolina Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 93: Alabama Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 94: Mississippi Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 95: Louisiana Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: Arkansas Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: Kentucky Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: Oklahoma Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: Virginia Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 100: Maryland Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 101: West Virginia Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 102: Delaware Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 103: District of Columbia Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 104: Midwest Region U.S. Outpatient Diagnostic Imaging Devices Market Share and Leading Players, 2025
FIGURE 105: Midwest Region Market Share Analysis by State, 2025
FIGURE 106: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 107: Illinois Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 108: Ohio Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 109: Michigan Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 110: Minnesota Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 111: Indiana Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 112: Wisconsin Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 113: Missouri Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 114: Iowa Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 115: Kansas Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 116: Nebraska Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 117: North Dakota Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 118: South Dakota Outpatient Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 119: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 120: Company Positioning Matrix
FIGURE 121: Key Player Product Portfolio Benchmarking
FIGURE 122: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 123: Outpatient Diagnostic Imaging Innovation Roadmap
FIGURE 124: Photon-Counting and Spectral CT Adoption Roadmap
FIGURE 125: Compact, Helium-Light and Portable MRI Opportunity Map
FIGURE 126: Handheld Ultrasound and Portable Imaging Growth Roadmap
FIGURE 127: AI-Enabled Imaging Workflow Adoption Roadmap
FIGURE 128: Cloud-Native Enterprise Imaging and Remote Scanning Roadmap
FIGURE 129: Future Market Scenario Analysis, 2026–2035
FIGURE 130: Disruptive Technologies Impact Matrix
FIGURE 131: Emerging Business Trends Matrix
FIGURE 132: Investment Prioritization Matrix
FIGURE 133: Strategic Growth Roadmap for U.S. Outpatient Diagnostic Imaging Device Companies
FIGURE 134: Go-to-Market Strategy Framework
FIGURE 135: Product Positioning and Portfolio Expansion Framework
FIGURE 136: Report Scope and Disclaimer Framework